News articles about MedAssets (NASDAQ:MDAS) have been trending somewhat positive this week, according to Accern Sentiment. The research firm identifies positive and negative media coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. MedAssets earned a news impact score of 0.10 on Accern’s scale. Accern also assigned news coverage about the technology company an impact score of 45.0091899549729 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

TRADEMARK VIOLATION NOTICE: “Somewhat Positive News Coverage Somewhat Unlikely to Affect MedAssets (MDAS) Share Price” was first reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are reading this report on another website, it was copied illegally and reposted in violation of US & international trademark & copyright laws. The correct version of this report can be read at https://theolympiareport.com/2017/10/20/somewhat-positive-news-coverage-somewhat-unlikely-to-affect-medassets-mdas-share-price.html.

MedAssets Company Profile

MedAssets, Inc (MedAssets) provides technology-enabled products and services to healthcare organizations, including hospitals, health systems, non-acute healthcare providers, payers, other service providers and product manufacturers. The Company operates its business through two business segments: Spend and Clinical Resource Management (SCM) and Revenue Cycle Management (RCM).

Insider Buying and Selling by Quarter for MedAssets (NASDAQ:MDAS)

Receive News & Ratings for MedAssets Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedAssets Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.